Opportunities this week:
- GSK (Overweight PT 2420p c. 28% upside) – Recap on investment thesis and ACL inclusion
- Glanbia (Overweight, PT €28.50, +51% Upside) – Update post sell-off last week.
- Uniphar (Overweight PT €6.00, +49% Upside) – Recap on last week’s meeting with management.